U.S. Court of Appeals for the Federal Circuit, 2016

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc.

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc.
U.S. Court of Appeals for the Federal Circuit · Decided November 8, 2016

Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc.

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ AMNEAL PHARMACEUTICALS, LLC, Appellant v. ENDO PHARMACEUTICALS INC., Appellee ______________________ 2016-1217 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2014- 00360, IPR2014-01365. ______________________ JUDGMENT ______________________ BRENDA L. JOLY, Robins Kaplan LLP, Minneapolis, MN, argued for appellant. Also represented by JACOB M.

HOLDREITH, JAMIE R. KURTZ; OREN D. LANGER, New York, NY.

JOSEPH A. MAHONEY, Mayer Brown, LLP, Chicago, IL, argued for appellee. Also represented by ERICK J. PALMER.

THOMAS W. KRAUSE, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, for intervenor Michelle K. Lee. Also represented by MONICA BARNES LATEEF, FRANCES LYNCH, JOSEPH MATAL, SCOTT WEIDENFELLER. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (LOURIE, MOORE, and O’MALLEY, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

November 8, 2016 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.